Vivos Therapeutics (VVOS) Invested Capital (2019 - 2026)
Vivos Therapeutics (VVOS) reported Invested Capital of $6.2 million for Q1 2026, up 39.8% year-over-year from $4.4 million in Q1 2025, and up 545.8% on a QoQ basis from -$1.4 million in Q4 2025.
Vivos Therapeutics (VVOS) has 8 years of Invested Capital data on file, last reported at $6.2 million in Q1 2026.
- Quarterly Invested Capital rose 39.8% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (up 39.8% YoY) and the FY2025 annual result came in at -$1.4 million, down 117.37% from the prior year.
- Invested Capital rose to $6.2 million in Q1 2026 per VVOS's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Invested Capital topped out at $21.0 million in Q1 2022 and bottomed at -$1.4 million in Q4 2025.
- The 5-year median for Invested Capital is $4.8 million (2022), against an average of $5.8 million.
- The widest annual swing landed in 2024, when Invested Capital jumped 16563.04%; it then slumped 117.37% in 2025.
- Tracing VVOS's Invested Capital over 5 years: stood at $4.8 million in 2022, then slumped by 91.44% to $411000.0 in 2023, then jumped by 1835.28% to $8.0 million in 2024, then plunged by 117.37% to -$1.4 million in 2025, then surged by 545.8% to $6.2 million in 2026.
- Per Business Quant, the three latest VVOS Invested Capital figures stand at $6.2 million (Q1 2026), -$1.4 million (Q4 2025), and $2.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 86.11 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 23.48 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.39 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 20.80 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.01 Bn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | 6.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.16 Mn |
| Dec 31, 2025 | -1.32 Mn |
| Sep 30, 2025 | 2.87 Mn |
| Jun 30, 2025 | 4.74 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 7.95 Mn |
| Sep 30, 2024 | 7.67 Mn |
| Jun 30, 2024 | 6.35 Mn |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 411,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 6.99 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Sep 30, 2022 | 9.86 Mn |
| Jun 30, 2022 | 14.84 Mn |
| Mar 31, 2022 | 21.04 Mn |
| Dec 31, 2021 | 26.80 Mn |
| Sep 30, 2021 | 33.73 Mn |
| Jun 30, 2021 | 37.74 Mn |
| Mar 31, 2021 | 15.50 Mn |
| Dec 31, 2020 | 18.21 Mn |
| Sep 30, 2020 | -1.93 Mn |
| Jun 30, 2020 | -2.20 Mn |
| Mar 31, 2020 | -1.51 Mn |
| Dec 31, 2019 | 766,535.00 |